home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Softening Bone

 
  April, 3 2009 2:57
your information resource in human molecular genetics
 
     

A molecular mechanism that promotes bone destruction could be harnessed to combat osteoporosis, suggests a paper online in Nature Medicine.

Bone formation depends on a balance between cells that create it -- osteoblasts -- and cells that destroy it -- osteoclasts. Understanding the mechanisms that control the origin and function of these cells is crucial for developing treatments for diseases such as osteoporosis.

Kurt Redlich and colleagues report that the C-C chemokine receptor-2 (CCR2) is crucially involved in the regulation of bone mass by promoting the appearance of osteoclasts. The group found that mice lacking CCR2 have high bone mass owing to a decrease in number, size and function of osteoclasts. At the molecular level, activation of CCR2 in osteoclast progenitor cells results in increased expression of a molecule known as RANK, which enabled these cells to respond to signals that drive osteoclast differentiation.

In a model of postmenopausal osteoporosis -- mice that underwent ovary removal and therefore have less oestrogen -- CCR2 levels increased, thereby increasing RANK and the differentiation potential of osteoclast progenitor cells. As a result, mice lacking CCR2 are resistant to bone loss associated with reduced oestrogen. CCR2 activation could therefore be a target to combat postmenopausal osteoporosis.

Author contact:

Kurt Redlich (Medical University Vienna, Austria)
E-mail: kurt.redlich@meduniwien.ac.at

Abstract available online.

(C) Nature Medicine press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.